Anti-Inflammatory Drug Target for Alzheimer’s, TBI, and Neurodegenerative Disease Identified

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 05 Oct, 21:06 UTC

A study in human monocyte-derived microglia and human brain tissue slices suggests that inflammatory brain conditions, including traumatic brain injury and neurodegenerative diseases such as Alzheimer's disease, could be treated using an existing drug candidate targeting P2X7R. The post…

science

Sources

• T2Anti-Inflammatory Drug Target for Alzheimer’s, TBI, and Neurodegenerative Disease IdentifiedFierce Biotech / Fierce Healthcare / MedCity / GEN05 Oct, 21:06